跳至主要内容
临床试验/NCT03717532
NCT03717532终止不适用

Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2019年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
1
主要终点
Decrease in Pain measured by Visual Analog Scale (VAS)

研究概览

简要总结

The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA class I-II
  • Diagnosed with patellofemoral pain syndrome

排除标准

  • Patients with confirmed radiographic evidence explaining knee pain
  • Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
  • Younger than 18 years of age or older than 65
  • Any patient considered a vulnerable subject
  • Patients with impaired circulation, peripheral vascular compromise, Previous revascularization of the extremity, or severe hypertension
  • Patients with Sickle cell anemia or venous thromboembolism
  • Patients with Sickle cell anemia or venous thromboembolism
  • Patients with cancer or Lymphectomies
  • Patients with increased intracranial pressure

结局指标

主要结局

Decrease in Pain measured by Visual Analog Scale (VAS)

时间窗: 6 Weeks

100-mm horizontal line anchored at one end with the words "no pain" and at the other end with the words "worst pain imaginable."

Increase in Muscle Mass Measured by Biodex

时间窗: 6 Weeks

Biodex dynamometer is used under standard of care to measure the extensor strength of both legs and have bilateral thigh circumference measured

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Blood Flow Restriction Therapy in Patellofemoral... | 临床试验